Breaking News
Get 50% Off 0

Search Results for "APLS ":

Results: 298

Quotes

APLS Leverage Shares -1x Apple ETP Securities ETF - London etf
Show all (1)

News

RBC Capital raises Biogen stock price target on lupus drug potential
By Investing.com

Investing.com - RBC Capital raised its price target on Biogen Inc. (NASDAQ:BIIB) to $260 from $240 while maintaining an Outperform rating on the shares. The stock currently trades at $218.12, near its...

Veeva stock gains as Biogen selects Vault CRM globally
By Investing.com

Investing.com - Veeva Systems announced that Biogen has committed to Vault CRM globally, according to a press release issued today. Biogen sits just outside the top 20 pharmaceutical companies on some...

Apellis reports SYFOVRE delayed geographic atrophy progression by 1.5 years
By Investing.com

Apellis Pharmaceuticals Inc. (APLS) announced results from a five-year analysis of its GALE extension study showing that SYFOVRE delayed geographic atrophy lesion growth by approximately 1.5 years...

Show all (297)
Results: 1

Refine Results

Instrument Type

Region

 

Country

Exchange

Sector

 

Industry

 
Results: 297

Refine Results

Date

Date
 

Category

Provider

 

News

{{title}}
By {{provider}}

{{content}}

Please try another search

Results: 0

Refine Results

Date

Date
 

Category

Author

Analysis

{{title}}
By {{provider}}

{{content}}

Results: 0

Refine Results

Country

Importance

Economic Events

Results: 0

Tools & Sections

Results: 0

Authors

Continue with Apple
Continue with Google
or
Sign up with Email